LiveMint: Doctors Without Borders opposes Pfizer’s pneumonia vaccine patent in India
“Médecins Sans Frontières (MSF)/Doctors Without Borders, a Paris-based international humanitarian-aid non-governmental organization, on Friday said it has filed a ‘patent opposition’ in India to prevent U.S. pharmaceutical company Pfizer Inc. from getting a patent on the pneumococcal conjugate vaccine (PCV13), so more affordable versions can become available to developing countries and humanitarian organizations…” (Pila, 3/14).

Reuters: Médecins Sans Frontières files to block Pfizer patent on pneumonia vaccine in India
“…Some of the world’s poorest countries and medical charities such as Médecins Sans Frontières (MSF) depend on India’s robust pharmaceutical industry to make cheaper forms of drugs and vaccines developed by big Western pharmaceutical companies such as Pfizer. If India granted Pfizer a patent on its Prevnar 13 pneumonia vaccine, Indian firms would not be able to produce affordable versions of it for domestic use or exports, MSF said…” (Siddiqui, 3/11).